We are a biotech accelerator established in 2013 based in the UK and in Italy. We identify promising compounds from new molecular entities and repurposed drugs and partner with academia, research institutions and biotech companies based globally.
The compounds are incubated, de-risked and developed as drug candidates for pre-clinical and/or clinical programs.
Successful projects become the assets for the creation of stand-alone companies partnering with financial investors, biopharma companies or seeking dedicated grants and loans.